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ABSTRACT  
The accurate and precise HPLC analytical method validated for the determination of Amlodipine besylate  in pharmaceutical dosage form. The 
chromatographic separation is carried out on shimadzu HPLC system (LC-2010 CHT)  with  UV Vissible  detector and C18(150mm x3.9 mm) 5 
μm Column. The Mobile phase consists of Acetonitrile: Methanol: PH 3.0 Buffer (15 V: 35 V: 50 V) , at the flow rate  of  1.0 ml/min and elutes 
were monitoring  at 237 nm. The observed retention time for Amlodipine besylate was 12.3 min. The % RSD for system precision was 0.41 % 
and Method precision was 0.58 %.  The method was found to linear (R=0.99996) in the Concentration range of 35-105 μg/ml (50 to 150%). The 
accuracy was in between 99.50-99.91%.  
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INTRODUCTION 
Amlodipine besylate is a dihydropyridine calcium channel 
blocker indicated in treatment of mild to moderate   
essential hypertention  and   for  the management of chronic  
stable angina in  pattients. Amlodipine besylate (Figure 1) is 
chemically name as 3-ethyl 5-methyl (4RS)-2-[(2-
aminoethoxy) methyl]-4-(2-chlorophenyl)-6-methyl-1,4- 
dihydropyridine-3,5-dicarboxylate  benzene  sulphonate. 
Molecular formula for  Amlodipine  besylate  is 
C26H31ClN2O8S   and  Molecular weight is 567.1 
Figure 1: Chemical Structure of Amlodipine besylate 
Literature  review reveals that there few HPLC method 
available for the determination of Assay contenets of 
Amlodipine besylate in Tablet dosage forms.This novel  
proposed method contribute quick estimation and correct 
peak shape. The objective of this study was to develop 
analytical method in order to identify the amount of 
Amlodipine besylate in Tablet dosage forms. 
EXPERIMENTAL 
Reagents and Chemicals: Triethylamine and 
orthophosphoric acid were used of Analytical reagent 
grade(Make: Fisher Scientific) however solvents used for 
Mobile phase Acetonitrile and Methanol of HPLC grade 
(Make :Fisher Scientific). 
Instrumentation: The method development was performed 
with shimadzu HPLC system(LC-2010 CHT)  having  UV 
Vissible  detector .     
Reference Solution: Weighed accurately 70 mg of   
Amlodipine besylate (equivalent to 50.47 mg of Amlodipine) 
transfer into 100 ml of Volumetric flask dissolve it in mobile 
phase and make the volume upto mark.Transfer 5 ml of this 
solution to 50 ml of  Volumetric flask and make the volume 
with mobile phase.    
Test Solution: Take 20 tablets of Amlodipine besylate and 
crushed .Weighed  to powder accurately  equivalent to 70 
mg of Amlodipine besylate transfer into 100 ml of 
Volumetric flask dissolve it in mobile phase and make the 
volume upto mark.Transfer 5 ml of this solution to 50 ml of  
Volumetric flask and make the volume with mobile phase.      
(Note: use 0.45 μm   filter for solution filtration)
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Factor Calculation:     
 Factor  =
                              
                                     
 =
       
      
=0.721 
Assay Calculation: 
     (in mg/Tablet) =  AT     X   WS    X    5    X  100   X  50   X   P     X  0.721  X AW 
                                        AS          100          50       WT        5          100 
     
 % Assay  =    mg/tablet 
                               LC 
Where, 
           AT         = Area of Test Solution 
          AS          = Area of Standard Solution 
          WS         =  Weight of Standard 
          WT         =  Weight of Test 
          P             = Potency of Standard 
         AW         = Average Weight of  20 Tablets 
         LC          = Label Claim of Amlodipine  mentioned on Carton or Strip of  tablet 
       All the  acceptance crieteria given  in Table 1. 
 
Table 1: Acceptance criteria for System suitability 
Sr. No Parameter Limit/ Acceptance criteria 
1 Theoretical plates Not less than 2000 
2 Tailing Factor Not more than 1.5 
3 % RSD for Area of replicates Injection Not More than 2.0 % 
 
RESULT AND DISCUSSION 
 The method was developed with the composition of Acetonitrile: Methanol: PH 3.0 Buffer (15 V: 35 V: 50 V) was showed to 
good symmetric peaks and  less tailing factor. The optimizes parameters are shown in Table 2. 
Table 2 :  Optimized Chromatographic Analytical method  condition 
Sr. 
No. 
Parameter Description /Value 
1 Stationary 
Phase(Column) 
C18(150mm x3.9 mm) 5 μm, Preferred to   Inertsil ODS-3 . 
 
2 Mobile Phase 15 V Acetonitrile :35 V Methanol:50 V Buffer (Prepared by 7 ml of TEA in 1000 ml HPLC 
Water. Adjusted PH 3.0 with 25 % Orthophosphoric Acid). Filter  through 0.45 μm 
3 Flow rate 1 ml/min. 
4 Detection wavelength 237 nm 
5 Detector UV Visible 
6 Injection Volume 10 μl  
7 Column temperature 30 0C 




METHOD VALIDATION: The different method validation 
parameters were   performed as per   ICH guidelines.  All   
the   parameters showed good   result and they complies to 
specified acceptance criteria. 
System Suitability:   The  method  for analytical  
determination  of  Amlodipine  besylate  was validated and 
tested for system suitability according to ICH 
guidelines.Before start to experiment  Stabilize the HPLC 
system for 30 minutes  and Chromatographic system used 
for analysis must pass system suitability .Inject the Blank , 
Standard and Test Solution(Each single Injection).The 
Parameter such as Tailing factor and theoretical plates 
should meet the acceptance criteria. 
 Result of System Suitability: All system suitability 
parameter are found within acceptance criteria. The 
chromatogram shown in figure 2 and Results are tabulated 
in Table 3 
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Table 3:   System suitability result of Amlodipine Besylate 
Sr. 
No 
Parameter Results Acceptance Criteria 
1 Theoretical plates 4774 Not less than 2000 
2 Tailing Factor 1.0 Not More than 2.0 
 
 
Figure 2 : Typical Chromatogram for Standard Solution 
 
PRECISION:  According to the ICH guidelines    the precision 
of   an analytical procedure determined   the   closeness   of    
results    obtained    by multiple measurement of the same 
homogeneous sample. Repeatability (System precision and 
method precision) were done to show the precision of the 
method. To demonstrate repeatability (System precision)  of  
the  test  method  six  replicate  injection  of Reference 
solution were analysed and  % RSD of assay results was 
calculated. 
RESULT OF PRECISION: The % RSD of six standard Area 
(For system precision) and for  Six Assay result   (for method 
precision) was found within acceptance limit  tabulated in 
Table 4.  The acceptance criteria of  % RSD for  replicate area 
and Assay content should  be not more than 2.0% 
Table 4 : Result for Precision study (System  and Method) 
Sr. No Peak Area 
(For System precision) 
% Assay(For Method 
Precision) 
1 1441857 98.35 
2 1435981 99.32 
3 1448956 99.85 
4 1436987 99.58 
5 1449587 98.95 
6 1439589 98.69 
Mean 1442160 99.12 
SD 5881.97 0.57 
% RSD 0.41 0.58 
 
LINEARITY: Linearity   was   measured  by  varies the  
concentration of Amlodipine Besylate 50%, 80%,100% ,120 
% and 150% were injected into the HPLC System. A 
calibration  curve was made by plotting the Peak area vs 
concentration of standard solution. Correlation coefficient 
(R2) and linear regression equation were incorporated to 
statistically evaluate the linearity of the results  y = mx+b. 
Where, y = response, m=slope, x= concentration and 
b=intercept. Bias is the way of expression to show more 
imprecision calculated by intercept to area of 100% 
concentration.  
RESULTS OF LINEARITY: The    observed value for 
correlation coefficient  0.99996 ( limit:not less than 0.9999) 
and Bias 0.74 (Limit ±3) found within acceptance criteria in 
the Concentration range of  35-105 μg/ml. The linearity data 
shown in the Table 5 and Calibration plots are given in the  
Figure 3 . 
Table 5:  Results of  Linearity  study 
Sr. No Concentration( in %  ) Peak area 
1 50% 438598 
2 80% 701442 
3 100% 876758 
4 120% 1052464 
5 150% 1305698 
Correlation:  0.99996 
Slope             :   8685.42 
Intercept    :   6449.93 
Bias               :    0.74 
 
 
Figure 3 : Calibration curve between concentration   and  
Response area 
RECOVERY: The accuracy of  an  Analytical  procedure  
shows  to  closeness of result with the conventional   value. 
The  accuracy  of  the   method  was  planned by standard 
addition process.A known  amount    of  standard  weight  
added  at  different level   50%,100%  and 150% to get final 
concetration  of  35μg/ml, 70 μg/ml  and  105 μg/ml  than  
there  solution  were analysed for Assay content.Triplicate 
set of each levels were prepered for the experiment. 
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RESULTS OF RECOVERY : The  concentration  of  50%  
solution  showed    % Mean  recovery 99.50 % and  % RSD  
0.34%. The concentration of 100%  solution showed % Mean 
recovery 99.58 % and % RSD  0.34%. The concentration of 
150% solution showed % Mean recovery 99.91 % and % 
RSD 0.03%. All the result were tabulated in Table 6.The 
recovery Acceptance limit of Assay content should be  98 to 
102 % and % RSD not  more than 2.0%. 
 
Table 6:   Results  of  Accuracy   study 
Spiked Concentration Amount  added ( in mg) Amount  recovered ( in mg) % Recovery 
50%   -01 35.25 35.13 99.66 % 
50%  -02 34.98 34.67 99.11% 
50%  -03 35.68 35.58 99.72% 
100%-01 70.35 70.14 99.70 % 
100%-02 69.85 69.74 99.84 % 
 100%-03 71.25 70.68 99.20% 
150%-01 105.68 105.58 99.91 % 
150%-02 104.85 104.79 99.94% 
150%-03 104.35 104.23 99.89% 
Mean for 50%  :  99.50                                                                        RSD for  50%   :  0.34 
Mean for 100% : 99.58                                                                         RSD for  100% : 0.34 
Mean for 150% : 99.91                                                                         RSD for  150%  :0.03 
 
 
Table 7:  Summary of all results 
Validation parameter                                                                                          Results
Linearity 
Coefficient of correlation                                                                              0.99996
Bias         0.74 
Precision 
System Precision                                                                                           0.41 % 
Method Precision                                                                                          0.58% 
Accuracy 
50%                                                                                                              99.50%
100%                                                                                                            99.58%
150%                                                                                                            99.91%
 
CONCLUSION 
The developed  and  validated  HPLC  method  was  showed  
good symmetric peak and less tailing factor.  The method   
was exposed   good   precision,  Accuracy   and   the  
observed  value during experiment meet  with  specified  
acceptance   limit.  The linearity   graph showed good 
correlation between  different   concentration solution  and 
area, the  R2  value were found to be 0.99996.  The proposed   
method can help to research scholar and Quality control in 
routine analysis. The result of assay content for   
pharmaceutical formulation is in good agreement with the 
label claim of drugs. 
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